ABBOTT LABORATORIES — Director's Dealing 2017

Apr 28, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-04-26

Reporting Person: MANNING JOSEPH J (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-26	Common shares without par value	M	3200	$26.6973	Acquired	26224	Direct
2017-04-26	Common shares without par value	S	200	$43.94	Disposed	26024	Direct
2017-04-26	Common shares without par value	S	100	$43.941	Disposed	25924	Direct
2017-04-26	Common shares without par value	S	100	$43.943	Disposed	25824	Direct
2017-04-26	Common shares without par value	S	500	$43.945	Disposed	25324	Direct
2017-04-26	Common shares without par value	S	2300	$43.947	Disposed	23024	Direct
2017-04-26	Common shares without par value	S	400	$43.971	Disposed	22624	Direct
2017-04-26	Common shares without par value	S	600	$43.973	Disposed	22024	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-26	Option (right to buy)	$26.6973	M	3200	Disposed	2018-02-14	Common shares (3200)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.